Skip to content

BIOCLIN

Active
Public limited company·Detailhandel in farmaceutische producten· 49 yrs active
Troonstraat 60 ·8400 Oostende, Belgium
KBO/BCE: BE 0416.553.335
Watch Print / PDF
Age49 yrs
Board1
Real estate1 parcel · 1,596 m²

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of BIOCLIN is 0.4% (very low). The company has been active since 1976 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 10 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 30-06-2025 31 d early 2025-00212572
31-12-2023 31-07-2024 18-07-2024 13 d early 2024-00270101
31-12-2022 31-07-2023 19-07-2023 12 d early 2023-00257192
31-12-2021 31-07-2022 24-06-2022 37 d early 2022-20103407
31-12-2020 31-07-2021 25-06-2021 36 d early 2021-26300317
31-12-2019 31-07-2020 26-06-2020 35 d early 2020-22700218
31-12-2018 31-07-2019 25-08-2019 25 d late 2019-52500092
31-12-2017 31-07-2018 30-08-2018 30 d late 2018-58500145
31-12-2016 31-07-2017 10-07-2017 21 d early 2017-30300523
31-12-2015 31-07-2016 08-08-2016 8 d late 2016-40900200

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
Long-established
Founded in 1976, 49 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.4% Very low
0%0,5%1,5%4%10%≥25%
Long track record −Higher-failure-rate sector +Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Annual accounts & ratios

Source: NBB
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (verkort). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 verkort 30-06-2025 2025-00212572
31-12-2023 verkort 18-07-2024 2024-00270101
31-12-2022 verkort 19-07-2023 2023-00257192
31-12-2021 verkort 24-06-2022 2022-20103407
31-12-2020 verkort 25-06-2021 2021-26300317
31-12-2019 verkort 26-06-2020 2020-22700218
31-12-2018 verkort 25-08-2019 2019-52500092
31-12-2017 verkort 30-08-2018 2018-58500145
31-12-2016 verkort 10-07-2017 2017-30300523
31-12-2015 verkort 08-08-2016 2016-40900200

Directors

Directors & mandates

1 director
Current directors & mandates
  • Lien Matton
    Director
    State Gazette act 26102608 (10-08-2026)
    Current
    01-02-2026 → present
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Detailhandel in farmaceutische producten(47730)
Legal form Public limited company(014)
Incorporation30-10-1976
StatusActive
Postal code8400

Structure & network

Locations & real estate

Establishment units

1 location
BIOCLIN NV Apotheek Baetsle
Troonstraat 60, 8400 Oostendede vervaardiging van salicylzuur en o-acetylsalicylzuur
since 19802.017.208.238
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area1,596 m²
Buildings1
Building footprint487 m²
Volume (LiDAR)11,585 m³
Tallest building28.3 m · ±8 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
35384A0089/00N040 Flanders 1,596 m² 1 · 487 m² 28.3 m · 8 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

1 verified act

What every Belgian State Gazette publication actually says, each act broken down into appointments, capital movements, seat moves and statute amendments.

2026
10-08-2026 General meeting · Director reappointment · Permanent representative
7 facts
  • General meeting , 16/06/2026
  • Director reappointment, NV Lithi-Pharma (bestuurder)
  • Director reappointment, BV Camba-Pharma (bestuurder)
  • Director reappointment, Lien Matton (bestuurder)
  • Permanent representative, Thierry Baetslé
  • Permanent representative, Camille Baetslé
+1 further fact

Analysis

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, nearest first

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Apotheken47730Detailhandel in farmaceutische producten47730Apothekers52310Apothekers52310
Primary activity highlighted.
Names & trade names
Legal nameNL BIOCLIN
Registered office
Troonstraat 60
8400 Oostende, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.